FAMILLE DES MIARN-212/132 COMME CIBLE THERAPEUTIQUE

• 收藏
• 分享

专利权人:

MEDIZINISCHE HOCHSCHULE HANNOVER;MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

发明人:

THUM, THOMAS,CHOWDHURY, KAMAL,UCAR, AHMET,GUPTA, SHASHI KUMAR

申请号：

CA3065098

公开号：

CA3065098A1

申请日:

2012.09.06

申请国别(地区):

CA

年份:

2013

代理人:

摘要：

The present invention refers to inhibitors of microRNAs, particularly ofmicroRNAsmiR-212 for use in medicine, particularly in the diagnosis, treatment orprevention of cardiacdisorders, e.g. cardiac hypertrophy-associated or autophagic disorders, andfurtherrefers to isolated nucleic acid molecules, particularly microRNAs miR-212 andrelatedsequences, for use in medicine, particularly human medicine, more particularlyin thediagnosis, treatment or prevention of disorders involving cardiac atrophyand/ordysfunctional autophagy, e.g. cardiac cachexia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/